ENTPD1 and rheumatoid arthritis: Specifically, it emphasizes the dynamic nature of CD39 and CD73 expression on lymphocytes, suggesting potential changes dependent on both time and context and implying a role in the altered immunoregulatory processes underlying RA pathophysiology.